Jaclyn Milici, DO
Surgery · Abington, PANPI 1740669225
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,004 of the $26,485 with a category attached, or 75.5%. Medtronic accounts for 76.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2021 at $11,899 and has fallen 96.1% since, to $466 in 2025. Among surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $230.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Cook Medical LLC$2K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$371
- Endologix LLC$310
- Smith+Nephew$253
- plus $1K from 23 others
What the payments were for
- Grants$20,00476%
- Food & beverage$5,02319%
- Education$1,4586%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $20,351 |
| Cook Medical LLC | 17 | $2,062 |
| W. L. Gore & Associates, Inc. | 20 | $1,903 |
| Boston Scientific | 5 | $371 |
| Endologix LLC | 11 | $310 |
| Smith+Nephew | 6 | $253 |
| Penumbra, Inc. | 3 | $202 |
| Baxter Healthcare | 4 | $134 |
| Medical Device Business Services, Inc. | 1 | $108 |
| Sanara Medtech Inc. | 2 | $102 |
| Angiodynamics, Inc. | 2 | $78 |
| Silk Road Medical, Inc. | 1 | $66 |
| Johnson & Johnson(2 entities) | 4 | $60 |
| Bard Peripheral Vascular, Inc. | 3 | $53 |
| Cvrx, Inc. | 2 | $52 |
| Hartmann USA, Inc. | 2 | $52 |
| Lemaitre Vascular, Inc. | 3 | $48 |
| Terumo Medical Corporation | 3 | $40 |
| Inari Medical, Inc. | 1 | $36 |
| Sirtex Medical Inc | 2 | $35 |
| Urgo Medical North America, LLC | 1 | $33 |
| Surmodics, Inc. | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $22 |
| Philips North America LLC | 1 | $20 |
| Abbott | 1 | $17 |
| Shockwave Medical, Inc | 1 | $15 |
| BD | 1 | $14 |
| Pfizer | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$19,000
- GORE VIABAHN VBX Balloon Expandable Endo$595
- EXCLUDER AAA Endoprosthesis$545
- ENDURANT IIS$457
- Zenith$240
- GORE TAG Conformable Thoracic Endoprosthesis$207
- GORE VIABAHN Endoprosthesis with Heparin$192
- GRAFIX PL$142
- STRAVIX PL$142
- Oasis$142
- GENERAL VASCULAR INTERVENTION$132
- Vascular Graft$125
- Indigo System$125
- Lunderquist$118
- AngioJet Ultra 5000A$117
- Zenith Spiral-Z$117
- Valiant Captivia$115
- Cook Medical AAA$101
How this compares
$26,485 in reported general payments places this provider in the 95th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 26 | $27,429 |
| EliquisApixaban | 17 | $13,529 |
| ClopidogrelClopidogrel Bisulfate | 63 | $521 |
| Cilostazol | 20 | $322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $60 | $27,42926 claims |
| PfizerEliquis | $13 | $13,52917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,424 surgery providers in Pennsylvania.
Other surgery in Abington
- Sean MarattoAbington$28K
- Andy KiserPittsburgh$1M
- Glenn SteeleDanville$698K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$619K
- Paul CesanekAllentown$469K
- Clark GerhartPlains$317K
- Irina YermilovPlymouth Meeting$315K
- Eric PauliHershey$202K
- Ariel AballayPittsburgh$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.